{
    "2021-07-20": [
        [
            {
                "time": "2021-07-20",
                "original_text": "晚间重要公告2021年7月20日星期二",
                "features": {
                    "keywords": [
                        "公告",
                        "2021",
                        "7月20日"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "北水大幅抛售腾讯逾33亿港元；南水买入恒瑞医药、万华化学",
                "features": {
                    "keywords": [
                        "北水",
                        "抛售",
                        "腾讯",
                        "南水",
                        "买入",
                        "恒瑞医药",
                        "万华化学"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "医药",
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "北向资金合计净流入30.65亿元，恒瑞医药、万华化学、复星医药净买入居前",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流入",
                        "恒瑞医药",
                        "万华化学",
                        "复星医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "恒瑞医药今日大宗交易成交26.50万股，成交价62.46元折价1.14%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "成交",
                        "折价"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "北向资金净买入恒瑞医药5.72亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "恒瑞医药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "最新出炉！7月20日沪深股通净流入30.65亿，其中5.72亿买入恒瑞医药",
                "features": {
                    "keywords": [
                        "沪深股通",
                        "净流入",
                        "恒瑞医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "北向资金今日净买入30.65亿元，持续加仓医药股",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "医药股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "恒瑞医药：SHR-1906注射液获得药物临床试验批准通知书",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR-1906",
                        "注射液",
                        "临床试验",
                        "批准"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-19",
                "original_text": "A股融资融券日报：两融余额增加6.19亿元（7月19日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "北向资金动向盘点：重手买入“医药”，谨防“德尔塔”",
                "features": {
                    "keywords": [
                        "北向资金",
                        "买入",
                        "医药",
                        "德尔塔"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}